Cyclerion Therapeutics Inc (CYCN) — Cash Flow Quality Index
Latest as of December 2024:
0.68x
Cyclerion Therapeutics Inc (CYCN) has a Cash Flow Quality Index of 0.68x as of December 2024. Operating cash flow of $360.00K is below net income of $530.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore CYCN long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
0.68x
Operating CF / Net Income
Operating Cash Flow
$360.00K
USD
Net Income
$530.00K
USD
Data as of
Dec 2024
Most recent filing
Annual Cash Flow Quality Index for Cyclerion Therapeutics Inc (None–None)
Year-by-year earnings quality comparison for Cyclerion Therapeutics Inc. For live market cap and the full company financial profile, see Cyclerion Therapeutics Inc market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.